Skip to main content
UniHealth

Doctor search

Teri A Longacre, MD

Pathology · Stanford

NPI 1528120896

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Longacre’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence G69115 · Current

Licensed to practise in California · since 1990 · expires 2027-09-30 · University of New Mexico School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$92,010

Medicare paid this office $92,010 for 817 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Pathology examination of tissue using a microscope, intermediate complexity440$31,932$33
Special stained specimen slides to examine tissue, each additional procedure108$12,129$25
Surgical pathology consultation and report on referred slides prepared elsewhere144$11,052$75
Surgical pathology consultation and report on referred material requiring preparation of slides111$9,143$79
Microscopic genetic analysis of tumor, manual137$8,680$37
See all 12 services
Every Original Medicare service billed
Pathology examination of tissue using a microscope, intermediate complexity440$31,932$33
Special stained specimen slides to examine tissue, each additional procedure108$12,129$25
Surgical pathology consultation and report on referred slides prepared elsewhere144$11,052$75
Surgical pathology consultation and report on referred material requiring preparation of slides111$9,143$79
Microscopic genetic analysis of tumor, manual137$8,680$37
Special stained specimen slides to examine tissue, initial procedure175$6,453$31
Pathology examination of tissue using a microscope, moderately high complexity44$5,265$74
Pathology examination of tissue using a microscope, high complexity30$4,196$131
Genetic sequencing localization, initial procedure25$965$39
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure13$738$57
Pathology examination of tissue using a microscope, moderately low complexity38$459$10
Genetic sequencing localization, each additional procedure11$334$30

Who their Medicare patients are

817 Original Medicare patients in 2024. Average age 72 · Under 65 8% · 85 and older 5% · Women 66% · Also on Medicaid 24% · Health risk score 1.43. At or below the middle of the specialty; the typical pathology clinician is at 1.55.

Conditions among them: High blood pressure 68% · Cancer 37% · Diabetes 27% · Coronary heart disease 23% · Chronic kidney disease 23% · Depression 19% · Atrial fibrillation 15% · Heart failure 13% · COPD 9% · Stroke 7% · Dementia 5%.

The office billed $1,092,796, Medicare allowed $116,862 and paid $92,010; for 2,411 services of 18 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20248172,411721.43$1,092,796$92,010
2023325984721.37$365,451$37,292
20227302,436721.30$789,527$96,676
20218492,760721.32$637,309$109,148
20209823,185721.50$697,041$127,250
20191,1473,205711.38$655,426$124,033
20181,2913,732711.48$776,977$147,693
20171,2733,617711.43$723,584$142,784
20169983,459711.43$738,885$142,429
20151,6434,467721.33$886,612$172,499
20141,4784,149721.28$828,667$145,111
20131,0012,828711.26$528,804$110,037

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Surgical pathology consultation and report on referred slides prepared elsewhere110$8,382$76
Pathology examination of tissue using a microscope, intermediate complexity123$7,940$26
Special stained specimen slides to examine tissue, each additional procedure61$7,363$26
Surgical pathology consultation and report on referred material requiring preparation of slides55$4,408$80
Special stained specimen slides to examine tissue, initial procedure87$3,031$32
Microscopic genetic analysis of tumor, manual53$2,722$39
Pathology examination of specimen during surgery, first tissue block11$991$58

2022: 13 services

Original Medicare services billed in 2022
Pathology examination of tissue using a microscope, intermediate complexity403$36,742$34
Surgical pathology consultation and report on referred slides prepared elsewhere189$14,504$75
Special stained specimen slides to examine tissue, each additional procedure125$12,746$26
Surgical pathology consultation and report on referred material requiring preparation of slides106$8,456$80
Special stained specimen slides to examine tissue, initial procedure206$7,827$32
Pathology examination of tissue using a microscope, moderately high complexity27$4,368$77
Pathology examination of tissue using a microscope, high complexity28$3,889$134
Microscopic genetic analysis of tumor, manual68$3,850$38
Pathology examination of specimen during surgery, first tissue block16$1,571$56
Genetic sequencing localization, initial procedure26$1,099$41
Special stained specimen slides to identify organisms including interpretation and report13$418$25
Special stained specimen slides to examine tissue including interpretation and report11$226$11
Pathology examination of tissue using a microscope, moderately low complexity11$127$10

2021: 13 services

Original Medicare services billed in 2021
Pathology examination of tissue using a microscope, intermediate complexity495$41,467$33
Surgical pathology consultation and report on referred slides prepared elsewhere221$17,231$76
Special stained specimen slides to examine tissue, each additional procedure151$16,133$27
Surgical pathology consultation and report on referred material requiring preparation of slides115$9,743$83
Special stained specimen slides to examine tissue, initial procedure234$8,913$33
Microscopic genetic analysis of tumor, manual69$4,285$40
Pathology examination of tissue using a microscope, moderately high complexity23$3,726$79
Pathology examination of tissue using a microscope, high complexity19$2,804$140
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure12$1,266$60
Pathology examination of specimen during surgery, first tissue block13$1,253$60
Genetic sequencing localization, initial procedure29$1,245$42
Special stained specimen slides to identify organisms including interpretation and report18$610$24
Pathology examination of tissue using a microscope, moderately low complexity17$186$10

2020: 13 services

Original Medicare services billed in 2020
Pathology examination of tissue using a microscope, intermediate complexity593$53,726$35
Surgical pathology consultation and report on referred slides prepared elsewhere219$17,835$78
Special stained specimen slides to examine tissue, each additional procedure168$17,087$27
Surgical pathology consultation and report on referred material requiring preparation of slides137$11,473$83
Special stained specimen slides to examine tissue, initial procedure285$10,969$34
Microscopic genetic analysis of tumor, manual101$6,118$41
Pathology examination of tissue using a microscope, moderately high complexity23$2,626$82
Pathology examination of tissue using a microscope, high complexity16$2,455$144
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure17$1,557$62
Special stained specimen slides to identify organisms including interpretation and report32$1,280$26
Genetic sequencing localization, initial procedure19$813$43
Pathology examination of tissue using a microscope, moderately low complexity25$292$11
Special stained specimen slides to examine tissue including interpretation and report15$235$12

2019: 15 services

Original Medicare services billed in 2019
Pathology examination of tissue using a microscope, intermediate complexity818$61,277$35
Surgical pathology consultation and report on referred slides prepared elsewhere192$15,242$77
Special stained specimen slides to examine tissue, each additional procedure135$14,734$28
Special stained specimen slides to examine tissue, initial procedure253$9,694$34
Surgical pathology consultation and report on referred material requiring preparation of slides99$7,984$81
Pathology examination of tissue using a microscope, moderately high complexity31$4,486$80
Pathology examination of tissue using a microscope, high complexity17$2,692$142
Microscopic genetic analysis of tumor, manual46$2,690$40
Pathology examination of specimen during surgery, first tissue block13$1,272$61
Genetic sequencing localization, initial procedure24$1,006$42
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure15$912$61
Special stained specimen slides to identify organisms including interpretation and report27$888$25
Special stained specimen slides to examine tissue including interpretation and report22$355$11
Pathology examination of tissue using a microscope, moderately low complexity22$271$11
Preparation of tissue for examination by removing any calcium present14$178$12

2018: 14 services

Original Medicare services billed in 2018
Pathology examination of tissue using a microscope, intermediate complexity786$58,506$34
Surgical pathology consultation and report on referred slides prepared elsewhere271$21,201$78
Special stained specimen slides to examine tissue, each additional procedure195$20,673$27
Surgical pathology consultation and report on referred material requiring preparation of slides172$14,233$81
Special stained specimen slides to examine tissue, initial procedure323$13,084$34
Microscopic genetic analysis of tumor, manual108$7,007$42
Pathology examination of tissue using a microscope, moderately high complexity38$4,959$80
Pathology examination of tissue using a microscope, high complexity21$2,853$136
Pathology examination of specimen during surgery, first tissue block20$1,945$61
Special stained specimen slides to identify organisms including interpretation and report30$965$25
Genetic sequencing localization, initial procedure15$630$42
Pathology examination of tissue using a microscope, moderately low complexity31$375$11
Special stained specimen slides to examine tissue including interpretation and report12$214$11
Preparation of tissue for examination by removing any calcium present11$132$12

2017: 12 services

Original Medicare services billed in 2017
Pathology examination of tissue using a microscope, intermediate complexity810$61,130$35
Surgical pathology consultation and report on referred slides prepared elsewhere257$20,228$77
Special stained specimen slides to examine tissue, each additional procedure181$17,087$27
Special stained specimen slides to examine tissue, initial procedure359$14,550$33
Surgical pathology consultation and report on referred material requiring preparation of slides171$13,423$78
Microscopic genetic analysis of tumor, manual95$6,510$52
Pathology examination of tissue using a microscope, moderately high complexity24$3,048$80
Pathology examination of tissue using a microscope, high complexity15$2,128$142
Special stained specimen slides to identify organisms including interpretation and report45$1,415$25
Pathology examination of specimen during surgery, first tissue block11$1,326$58
Special stained specimen slides to examine tissue including interpretation and report33$608$11
Pathology examination of tissue using a microscope, moderately low complexity16$176$11

2016: 13 services

Original Medicare services billed in 2016
Pathology examination of tissue using a microscope, intermediate complexity443$32,689$34
Special stained specimen slides to examine tissue, each additional procedure275$24,784$25
Surgical pathology consultation and report on referred slides prepared elsewhere258$20,027$77
Special stained specimen slides to examine tissue, initial procedure368$15,332$33
Surgical pathology consultation and report on referred material requiring preparation of slides188$14,377$76
Pathology examination of tissue using a microscope, moderately high complexity75$10,087$79
Microscopic genetic analysis of tumor, manual127$8,860$51
Pathology examination of tissue using a microscope, high complexity58$8,488$139
Pathology examination of specimen during surgery, first tissue block41$4,781$60
Special stained specimen slides to identify organisms including interpretation and report35$1,284$26
Pathology examination of tissue using a microscope, moderately low complexity40$435$11
Special stained specimen slides to examine tissue including interpretation and report20$393$11
Pathology examination of tissue using a microscope11$88$7

2015: 12 services

Original Medicare services billed in 2015
Pathology examination of tissue using a microscope, intermediate complexity1,087$72,144$34
Surgical pathology consultation and report on referred slides prepared elsewhere285$21,976$75
Special stained specimen slides to examine tissue, each additional procedure250$16,185$20
Special stained specimen slides to examine tissue, initial procedure407$14,622$33
Surgical pathology consultation and report on referred material requiring preparation of slides148$11,493$78
Pathology examination of tissue using a microscope, high complexity80$11,377$139
Pathology examination of tissue using a microscope, moderately high complexity81$9,996$78
Microscopic genetic analysis of tumor, manual83$6,147$50
Pathology examination of specimen during surgery, first tissue block49$4,439$59
Special stained specimen slides to identify organisms including interpretation and report53$2,052$25
Pathology examination of tissue using a microscope, moderately low complexity80$903$11
Special stained specimen slides to examine tissue including interpretation and report31$442$11

2014: 12 services

Original Medicare services billed in 2014
Pathology examination of tissue using a microscope, intermediate complexity906$53,601$32
Surgical pathology consultation and report on referred slides prepared elsewhere309$26,776$73
Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain384$11,272$27
Surgical pathology consultation and report on referred material requiring preparation of slides142$11,145$76
Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)256$10,127$11
Pathology examination of tissue using a microscope, high complexity64$8,740$134
Pathology examination of tissue using a microscope, moderately high complexity76$8,287$75
Microscopic genetic analysis of tumor, manual97$6,542$48
Pathology examination of specimen during surgery, first tissue block36$3,138$57
Special stained specimen slides to identify organisms including interpretation and report65$1,877$23
Pathology examination of tissue using a microscope, moderately low complexity74$848$10
Special stained specimen slides to examine tissue including interpretation and report24$465$11

2013: 11 services

Original Medicare services billed in 2013
Pathology examination of tissue using a microscope, intermediate complexity708$46,647$32
Special stained specimen slides to examine tissue, initial procedure184$23,511$37
Surgical pathology consultation and report on referred slides prepared elsewhere108$9,362$70
Pathology examination of tissue using a microscope, moderately high complexity76$8,458$74
Pathology examination of tissue using a microscope, high complexity46$6,578$132
Surgical pathology consultation and report on referred material requiring preparation of slides60$4,717$74
Special stained specimen slides to identify organisms including interpretation and report105$3,110$24
Pathology examination of specimen during surgery, first tissue block30$2,869$56
Microscopic genetic analysis of tumor, manual43$2,615$47
Pathology examination of tissue using a microscope, moderately low complexity60$666$10
Special stained specimen slides to examine tissue including interpretation and report26$479$11

Medicaid work

$29,028 in 2024

Medicaid paid $29,028 for 770 billed services this clinician did in 2024, up to 54 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
TISSUE EXAM BY PATHOLOGIST552$19,869
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure122$4,643
Consultation and report on referred slides prepared elsewhere44$2,087
TISSUE EXAM BY PATHOLOGIST19$1,638
TISSUE EXAM BY PATHOLOGIST33$792
Medicaid work by year
2024770554$29,028
202380239$4,230
2022382452$21,648
2021345351$22,009
2020429359$29,612
2019529281$27,690
20187885121$41,900
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
TISSUE EXAM BY PATHOLOGIST59$3,340
Consultation and report on referred slides prepared elsewhere21$890

2022

Largest Medicaid services in 2022
TISSUE EXAM BY PATHOLOGIST229$15,734
Consultation and report on referred slides prepared elsewhere67$3,513
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure73$1,986
IMHCHEM/IMCYTCHM EA ADD ANTB13$415

2021

Largest Medicaid services in 2021
TISSUE EXAM BY PATHOLOGIST253$18,055
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure64$2,713
Consultation and report on referred slides prepared elsewhere28$1,240

2020

Largest Medicaid services in 2020
TISSUE EXAM BY PATHOLOGIST302$24,392
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure101$3,858
Consultation and report on referred slides prepared elsewhere26$1,362

2019

Largest Medicaid services in 2019
TISSUE EXAM BY PATHOLOGIST441$24,806
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure88$2,884

2018

Largest Medicaid services in 2018
TISSUE EXAM BY PATHOLOGIST504$30,656
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure178$6,906
Consultation and report on referred slides prepared elsewhere55$2,791
IMHCHEM/IMCYTCHM EA ADD ANTB37$930
CONSLTJ&REPRT REFERRED MATRL REQUIRING PREPJ SLD14$617

Money from drug and device companies

$42,190 in 2025

Industry payments by year
202546$42,100$42,190
202411$1,245$1,245
202322$1,210$1,231
202111$1,125$1,125
202011$1,125$1,125
2019213$11,600$13,250

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Astellas Pharma EuropeVyloy$38,759
2 payments
  • Consulting for Vyloy · 2025-07-07 · $35,343
  • Consulting for Vyloy · 2025-02-10 · $3,416
VerastemAvmapki Fakzynja Co-Pack$3,039
2 payments
  • Consulting for Avmapki Fakzynja Co-Pack · 2025-12-11 · $1,251
  • Consulting for Avmapki Fakzynja Co-Pack · 2025-12-03 · $1,788
AstraZeneca Pharmaceuticals LPNone$303
1 payment
  • Consulting · 2025-01-01 · $303
GlaxoSmithKlineNone$90
1 payment
  • Meals · 2025-03-25 · $90
See all 6 published payments
Every published payment
VerastemConsulting · 2025-12-11Avmapki Fakzynja Co-Pack$1,251
VerastemConsulting · 2025-12-03Avmapki Fakzynja Co-Pack$1,788
Astellas Pharma EuropeConsulting · 2025-07-07Vyloy$35,343
GlaxoSmithKlineMeals · 2025-03-25None$90
Astellas Pharma EuropeConsulting · 2025-02-10Vyloy$3,416
AstraZeneca Pharmaceuticals LPConsulting · 2025-01-01None$303
See earlier years (2024, 2023, 2021, 2020, 2019)

2024: $1,245

Payments by company in 2024
Blueprint MedicinesAyvakit$1,245
1 payment
  • Honoraria for Ayvakit · 2024-04-16 · $1,245

2023: $1,231

Payments by company in 2023
AstraZeneca Pharmaceuticals LPNone$1,210
1 payment
  • Consulting · 2023-12-26 · $1,210
Hologic Sales and ServicePanther Fusion$21
1 payment
  • Meals for Panther Fusion · 2023-03-17 · $21

2021: $1,125

Payments by company in 2021
Merck Sharp & DohmeNone$1,125
1 payment
  • Consulting · 2021-06-18 · $1,125

2020: $1,125

Payments by company in 2020
Merck Sharp & DohmeNone$1,125
1 payment
  • Consulting · 2020-11-13 · $1,125

2019: $13,250

Payments by company in 2019
Astellas Pharma USNone$8,293
6 payments
  • Consulting · 2019-05-14 · $7,475
  • Meals · 2019-05-04 · $74
  • Meals · 2019-05-04 · $50
  • Meals · 2019-05-04 · $50
  • Travel · 2019-05-03 · $251
  • Travel · 2019-05-03 · $393
Merck Sharp & DohmeNone$4,956
7 payments
  • Travel · 2019-05-20 · $150
  • Consulting · 2019-05-20 · $4,125
  • Meals · 2019-05-03 · $30
  • Meals · 2019-05-03 · $50
  • Meals · 2019-05-03 · $57
  • Travel · 2019-05-02 · $262
  • Travel · 2019-05-02 · $281

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1528120896
Licence
CA G69115California G69115: Current · expires 2027-09-30
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZP0101X (207ZP0101X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-12-14
NPI last updated
2024-03-14
NPI record certified
2024-03-14

This is when the NPI record was last certified, not a medical board exam.